Clinical Trial Update: First Time in Human Study of Intravenous Interleukin-18 Antibody [Phase 1]

View source ↗

Summary

Phase 1, first-in-human study of intravenous interleukin-18 antibody for inflammatory bowel diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Interleukin-18 antibody (intravenous) (interleukin-18 antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: COMPLETED